Discover
BIO
Bio-Rad Laboratories, Inc.
356.25
1 x 349.30
1 x 356.61
bid
ask
+
1.71
0.48%
1 @ 04:00 PM
356.25 +0.00 (0.00%)
| Ytd | 17.58% | |
| 1y | 34.67% |
349.37
day range
358.69
236.73
52 week range
358.69
| Open | 349.37 | Prev Close | 354.54 | Low | 349.37 | High | 358.69 | Mkt Cap | 9.59B |
| Vol | 0.00 | Avg Vol | 365.78K | EPS | 9.28 | P/E | 38.39 | Forward P/E | 35.39 |
| Beta | 1.05 | Short Ratio | 3.09 | Inst. Own | 92.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 304.85 | 200-d Avg | 296.58 | 1yr Est | 329.00 |
| Income Statement | |||
| Total Revenue | 651.00M | ||
| Revenues (USD) | 651.00M | ||
| Cost of Revenue | 305.20M | ||
| Gross Profit | 345.80M | ||
| Operating Expenses | 273.20M | ||
| Research and Development Expense | 61.20M | ||
| Selling, General and Administrative Expense | 212.00M | ||
| Operating Income | 72.60M | ||
| Interest Expense | 12.10M | ||
| Income Tax Expense | 170.70M | ||
| Net Income | 371.40M | ||
| Net Income Common Stock | 371.40M | ||
| Net Income Common Stock (USD) | 371.40M | ||
| Consolidated Income | 371.40M | ||
| Earnings per Basic Share | 13.89 | ||
| Earnings per Basic Share (USD) | 13.89 | ||
| Earnings per Diluted Share | 13.85 | ||
| Earning Before Interest & Taxes (EBIT) | 554.20M | ||
| Earning Before Interest & Taxes (USD) | 554.20M | ||
| Weighted Average Shares | 26.75M | ||
| Weighted Average Shares Diluted | 26.81M | ||
| Balance Sheet | |||
| Cash and Equivalents | 517.00M | ||
| Cash and Equivalents (USD) | 517.00M | ||
| Investments | 6.83B | ||
| Investments Current | 1.10B | ||
| Investments Non-Current | 5.72B | ||
| Trade and Non-Trade Receivables | 441.80M | ||
| Current Assets | 3.02B | ||
| Property, Plant & Equipment Net | 671.90M | ||
| Total Assets | 10.25B | ||
| Debt Current | 434.30M | ||
| Total Debt | 1.37B | ||
| Current Liabilities | 961.30M | ||
| Debt Non-Current | 936.10M | ||
| Total Liabilities | 3.08B | ||
| Accumulated Retained Earnings (Deficit) | 8.02B | ||
| Accumulated Other Comprehensive Income | -271.30M | ||
| Shareholders Equity | 7.17B | ||
| Shareholders Equity (USD) | 7.17B | ||
| Assets Non-Current | 7.23B | ||
| Total Debt (USD) | 1.37B | ||
| Goodwill and Intangible Assets | 734.30M | ||
| Inventory | 780.60M | ||
| Liabilities Non-Current | 2.12B | ||
| Trade and Non-Trade Payables | 143.50M | ||
| Tax Liabilities | 1.06B | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -27.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.80M | ||
| Capital Expenditure | -32.10M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 1.10M | ||
| Issuance (Purchase) of Equity Shares | -27.30M | ||
| Issuance (Repayment) of Debt Securities | -200.00K | ||
| Net Cash Flow from Investing | -66.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -35.70M | ||
| Net Cash Flow from Operations | 98.70M | ||
| Effect of Exchange Rate Changes on Cash | 5.40M | ||